Global Anti-Aging Market (2020 to 2030)

0
157


Dublin, Nov. 16, 2020 (GLOBE NEWSWIRE) — The “Anti-Aging Market Research Report: By Product, Treatment, Demography – Global Industry Analysis and Growth Forecast to 2030” report has been added to ResearchAndMarkets.com’s offering.

The major driving factors for the anti-aging market are the rising number of awareness-raising seminars and conferences, surging geriatric population, increasing disposable income, technological advancements, expanding medical tourism sector, and escalating cosmetic surgery volume. These factors will lead to an increase in the industry revenue from $191.5 billion in 2019 to $421.4 billion in 2030, at an 8.1% CAGR during 2020-2030 (forecast period). Products used to diminish the signs of aging are easily available at physical stores and online portals.

A key factor aiding the anti-aging market advance is the rising number of seminars and conferences being organized to make plastic surgeons, students, and the general public about the advanced anti-aging treatments. For instance, the Aesthetic & Anti-Aging Medicine World Congress (AMWC) hosted by EuroMediCom (Informa Group) in April 2019 in Monte Carlo, Monaco, included five knowledge sharing and discussion sessions on anti-aging and aesthetics. Formerly, the Aesthetic & Anti-Aging Medicine World Congress 13th Edition was hosted in Thailand in September 2018 by the American Academy of Anti-Aging Medicine (A4M).

Another major reason the demand for anti-aging treatments and products is increasing is the booming geriatric population. The United Nations says that the number of people in the age group of 65 and above will surge from 703 million in 2019 to 1.5 billion by 2050. With age, people experience stem cell and fibrous tissue loss, which leads to dryness, wrinkles, sagging, and pigmentary alteration. Therefore, in order to continue looking young and attractive, the geriatric population regularly uses anti-aging remedies, which tighten and revitalize the skin, in addition to making people look young.

North America is the dominant region in the anti-aging market currently, owing to the rising plastic surgery volume and geriatric population. The UN expects the number of elderly people on the continent to increase to 96.2 million by 2050 from 59.9 million in 2019. This, coupled with the growing volume of plastic surgeries, is expected to result in a massive surge in the demand for various therapies and products that help people look young and aesthetically appealing.

Hence, as more people age and their awareness regarding how they can reverse or physically hide the effects of this process rises, the market will keep blossoming.

Key Topics Covered:

Chapter 1. Research Background

Chapter 2. Research Methodology

Chapter 3. Executive Summary

Chapter 4. Introduction
4.1 Definition of Market Segments
4.1.1 By Product
4.1.1.1 Anti-wrinkle
4.1.1.1.1 Botox
4.1.1.1.2 Dermal fillers
4.1.1.2 Hair color
4.1.1.3 UV absorption
4.1.1.4 Anti-stretch mark
4.1.1.5 Others
4.1.2 By Treatment
4.1.2.1 Hair restoration
4.1.2.2 Anti-pigmentation
4.1.2.3 Adult acne therapy
4.1.2.4 Breast augmentation
4.1.2.5 Liposuction
4.1.2.6 Chemical peel
4.1.2.7 Others
4.1.3 By Demography
4.1.3.1 Generation X
4.1.3.2 Baby boomers
4.1.3.3 Generation Y
4.2 Market Dynamics
4.2.1 Trends
4.2.1.1 Increasing inclination of consumers toward easy-to-use, at-home anti-aging devices
4.2.2 Drivers
4.2.2.1 Increasing awareness through seminars and conferences
4.2.2.2 Surge in geriatric population
4.2.2.3 Rising disposable income
4.2.2.4 Advancements in technology
4.2.2.5 Growing medical tourism industry
4.2.2.6 Increasing volume of anti-aging cosmetic procedures
4.2.2.7 Impact analysis of drivers on market forecast
4.2.3 Restraints
4.2.3.1 High cost of anti-aging devices
4.2.3.2 Stringent regulatory requirements
4.2.3.3 Risks and side-effects associated with the use of anti-aging devices
4.2.3.4 Impact analysis of restraints on market forecast
4.2.4 Opportunities
4.2.4.1 Unmet need for minimally or non-invasive treatments
4.2.4.2 Rising use of social networking and e-commerce platforms
4.3 Impact of COVID-19
4.4 Porter’s Five Forces Analysis
4.4.1 Bargaining Power of Buyers
4.4.2 Bargaining Power of Suppliers
4.4.3 Intensity of Rivalry
4.4.4 Threat of New Entrants
4.4.5 Threat of Substitutes
4.5 Target Audience – Demographics
4.5.1 Total Population, By Gender
4.5.2 Prevalence of Acne Vulgaris, By Gender
4.5.3 Total Population, By Age
4.5.4 Prevalence of Acne Vulgaris, By Age
4.5.5 Target Population for Skin/Rejuvenation and Anti-Aging Products, By Age
4.5.6 Male Target Population for Skin/Rejuvenation and Anti-Aging Products, By Age
4.5.7 Female Target Population for Skin/Rejuvenation and Anti-Aging Products, By Age
4.6 Regulatory Framework Analysis
4.6.1 North America
4.6.2 Europe
4.6.3 APAC
4.6.4 LATAM
4.6.5 MEA

Chapter 5. Global Market Size and Forecast
5.1 By Product
5.1.1 Anti-Wrinkle Market, by Type
5.2 By Treatment
5.3 By Demography
5.4 By Region

Chapter 6. North America Market Size and Forecast
6.1 By Product
6.1.1 Anti-Wrinkle Market, by Type
6.2 By Treatment
6.3 By Demography
6.4 By Country
6.4.1 U.S. Anti-Aging Market
6.4.1.1 By product
6.4.1.1.1 Anti-wrinkle market, by type
6.4.1.2 By treatment
6.4.1.3 By demography
6.4.2 Canada Anti-Aging Market
6.4.2.1 By product
6.4.2.1.1 Anti-wrinkle market, by type
6.4.2.2 By treatment
6.4.2.3 By demography

Chapter 7. Europe Market Size and Forecast
7.1 By Product
7.1.1 Anti-Wrinkle Market, by Type
7.2 By Treatment
7.3 By Demography
7.4 By Country
7.4.1 Germany Anti-Aging Market
7.4.1.1 By product
7.4.1.1.1 Anti-wrinkle market, by type
7.4.1.2 By treatment
7.4.1.3 By demography
7.4.2 U.K. Anti-Aging Market
7.4.2.1 By product
7.4.2.1.1 Anti-wrinkle market, by type
7.4.2.2 By treatment
7.4.2.3 By demography
7.4.3 France Anti-Aging Market
7.4.3.1 By product
7.4.3.1.1 Anti-wrinkle market, by type
7.4.3.2 By treatment
7.4.3.3 By demography
7.4.4 Italy Anti-Aging Market
7.4.4.1 By product
7.4.4.1.1 Anti-wrinkle market, by type
7.4.4.2 By treatment
7.4.4.3 By demography
7.4.5 Spain Anti-Aging Market
7.4.5.1 By product
7.4.5.1.1 Anti-wrinkle market, by type
7.4.5.2 By treatment
7.4.5.3 By demography

Chapter 8. APAC Market Size and Forecast
8.1 By Product
8.1.1 Anti-Wrinkle Market, by Type
8.2 By Treatment
8.3 By Demography
8.4 By Country
8.4.1 Japan Anti-Aging Market
8.4.1.1 By product
8.4.1.1.1 Anti-wrinkle market, by type
8.4.1.2 By treatment
8.4.1.3 By demography
8.4.2 China Anti-Aging Market
8.4.2.1 By product
8.4.2.1.1 Anti-wrinkle market, by type
8.4.2.2 By treatment
8.4.2.3 By demography
8.4.3 India Anti-Aging Market
8.4.3.1 By product
8.4.3.1.1 Anti-wrinkle market, by type
8.4.3.2 By treatment
8.4.3.3 By demography
8.4.4 South Korea Anti-Aging Market
8.4.4.1 By product
8.4.4.1.1 Anti-wrinkle market, by type
8.4.4.2 By treatment
8.4.4.3 By demography

Chapter 9. LATAM Market Size and Forecast
9.1 By Product
9.1.1 Anti-Wrinkle Market, by Type
9.2 By Treatment
9.3 By Demography
9.4 By Country
9.4.1 Brazil Anti-Aging Market
9.4.1.1 By product
9.4.1.1.1 Anti-wrinkle market, by type
9.4.1.2 By treatment
9.4.1.3 By demography
9.4.2 Mexico Anti-Aging Market
9.4.2.1 By product
9.4.2.1.1 Anti-wrinkle market, by type
9.4.2.2 By treatment
9.4.2.3 By demography

Chapter 10. MEA Market Size and Forecast
10.1 By Product
10.1.1 Anti-Wrinkle Market, by Type
10.2 By Treatment
10.3 By Demography
10.4 By Country
10.4.1 Saudi Arabia Anti-Aging Market
10.4.1.1 By product
10.4.1.1.1 Anti-wrinkle market, by type
10.4.1.2 By treatment
10.4.1.3 By demography

Chapter 11. Competitive Landscape
11.1 List of Players and Their Offerings
11.2 Product Benchmarking of Key Players
11.3 Strategic Developments of Key Players
11.3.1 Mergers and Acquisitions
11.3.2 Facility Expansions
11.3.3 Product Launches and Approvals
11.3.4 Partnerships and Collaborations
11.3.5 Other Developments

Chapter 12. Company Profiles
12.1 The Procter & Gamble Company
12.1.1 Business Overview
12.1.2 Product and Service Offerings
12.1.3 Key Financial Summary
12.2 Nu Skin Enterprises Inc.
12.2.1 Business Overview
12.2.2 Product and Service Offerings
12.2.3 Key Financial Summary
12.3 Hologic Inc.
12.3.1 Business Overview
12.3.2 Product and Service Offerings
12.3.3 Key Financial Summary
12.4 Candela Corporation
12.4.1 Business Overview
12.4.2 Product and Service Offerings
12.5 Home Skinovations Ltd.
12.5.1 Business Overview
12.5.2 Product and Service Offerings
12.6 Allergan plc
12.6.1 Business Overview
12.6.2 Product and Service Offerings
12.6.3 Key Financial Summary
12.7 The Estee Lauder Companies Inc.
12.7.1 Business Overview
12.7.2 Product and Service Offerings
12.7.3 Key Financial Summary
12.8 L’Oreal SA
12.8.1 Business Overview
12.8.2 Product and Service Offerings
12.8.3 Key Financial Summary
12.9 Orlane S.A.
12.9.1 Business Overview
12.9.2 Product and Service Offerings
12.10 Age Sciences Inc.
12.10.1 Business Overview
12.10.2 Product and Service Offerings
12.11 Alma Lasers Ltd.
12.11.1 Business Overview
12.11.2 Product and Service Offerings
12.12 Lumenis Ltd.
12.12.1 Business Overview
12.12.2 Product and Service Offerings
12.13 Panasonic Corporation
12.13.1 Business Overview
12.13.2 Product and Service Offerings
12.14 TRIA Beauty Inc.
12.14.1 Business Overview
12.14.2 Product and Service Offerings
12.15 Carol Cole Company Inc.
12.15.1 Business Overview
12.15.2 Product and Service Offerings
12.16 YA-MAN LTD.
12.16.1 Business Overview
12.16.2 Product and Service Offerings
12.17 MTG Co. Ltd.
12.17.1 Business Overview
12.17.2 Product and Service Offerings
12.18 Koninklijke Philips N.V.
12.18.1 Business Overview
12.18.2 Product and Service Offerings
12.18.3 Key Financial Summary
12.19 LightStim
12.19.1 Business Overview
12.19.2 Product and Service Offerings
12.20 Spectrum Brands Holdings Inc.
12.20.1 Business Overview
12.20.2 Product and Service Offerings
12.20.3 Key Financial Summary
12.21 Conair Corporation
12.21.1 Business Overview
12.21.2 Product and Service Offerings
12.22 Amorepacific Corporation
12.22.1 Business Overview
12.22.2 Product and Service Offerings
12.22.3 Key Financial Summary
12.23 Project E Beauty
12.23.1 Business Overview
12.23.2 Product and Service Offerings
12.24 Dr. Dennis Gross Skincare LLC
12.24.1 Business Overview
12.24.2 Product and Service Offerings
12.25 Beauty Bioscience Inc.
12.25.1 Business Overview
12.25.2 Product and Service Offerings
12.26 FOREO AB
12.26.1 Business Overview
12.26.2 Product and Service Offerings
12.27 Cyden Limited
12.27.1 Business Overview
12.27.2 Product and Service Offerings
12.28 Jeisys Medical Inc.
12.28.1 Business Overview
12.28.2 Product and Service Offerings
12.29 Imdad LLC
12.29.1 Business Overview
12.29.2 Product and Service Offerings

Chapter 13. Appendix

For more information about this report visit https://www.researchandmarkets.com/r/tb65yu

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900



Source link